5-Amino-1MQ for fat loss: what the science actually supports

What did @apex.nutrition actually say?

The creator pitched 5-Amino-1MQ as a compound that blocks an enzyme to "make sure your metabolism doesn't slow down," protects muscle mass from "decay," and, most boldly, "permanently oxidizes fat cells" so they "permanently shrink down." He also cited "a 7% increase in fat loss" in people who didn't even change their diet, and closed by inviting viewers to DM him for availability. That last part matters for context.

To be clear about what was said: the word "permanently" came up twice in relation to fat cells. That is a very specific, very strong claim for a compound with a handful of preclinical studies behind it. The creator also called it a peptide, which it technically is not. It is a small molecule inhibitor. That distinction is not just semantic, it affects how the compound is categorized, regulated, and understood.

Does the science back this up?

There is real research here, but almost none of it is human data. The mechanism the creator describes, inhibiting nicotinamide N-methyltransferase (NNMT), is scientifically legitimate and has generated genuine interest in metabolic research. The problem is the gap between mouse studies and the claims being made to a TikTok audience.

The foundational work comes from Neelakantan et al. (2019, Journal of Medicinal Chemistry), which showed 5-Amino-1MQ inhibited NNMT in vitro and in mouse adipocytes, reducing lipid accumulation. Hong et al. (2015, Cell Metabolism) demonstrated that NNMT knockdown in adipose tissue of mice produced a lean phenotype. These are meaningful findings. But mice with genetic NNMT suppression are not the same as a human taking an oral compound for six weeks. The "7% fat loss without dietary change" figure appears to reference unpublished or conference-presented data, not a peer-reviewed human clinical trial. No published human RCT on 5-Amino-1MQ exists in the major databases as of early 2025.

What did they get wrong (or right)?

The NNMT mechanism description is directionally correct, and that deserves credit. NNMT does regulate NAD+ metabolism and plays a role in adipocyte differentiation. Blocking it has shown promise in preclinical models. That part of the video is not nonsense.

What is wrong, and meaningfully so:

• Calling it a peptide is incorrect. 5-Amino-1MQ is a small molecule, specifically a methylquinolinium derivative. This is not a minor labeling error. Peptides and small molecules behave differently pharmacologically and are subject to different regulatory scrutiny.
• "Permanently oxidize fat cells" is not supported by any published evidence. Fat cell biology does not work this way in humans based on current data. Adipocytes can shrink (lose lipid content), but the claim of permanent structural change from this compound in humans is not established.
• The 7% fat loss statistic in non-dieting individuals is presented as settled science. It is not. No peer-reviewed human trial substantiates this specific figure.
• Soliciting DMs for "availability" on a compound with no FDA approval and limited safety data in humans raises real questions about how it is being sourced and sold.

What should you actually know?

5-Amino-1MQ is a genuinely interesting research compound. The NNMT pathway is a legitimate target in metabolic science, and researchers are actively studying it. But "interesting preclinical compound" and "proven fat loss solution" are completely different categories, and the video conflates them throughout.

The human safety profile of 5-Amino-1MQ is not well characterized. Long-term effects are unknown. NNMT also plays roles outside fat tissue, including in the liver and brain, and chronic inhibition effects in humans have not been studied adequately. Anyone considering this compound through a telehealth platform should be having a real clinical conversation, not responding to a TikTok DM for availability. If a provider is recommending this, they should be walking you through what the evidence actually shows, which is promising preclinical data and an absence of human trial data, not a list of guaranteed outcomes.

Bottom line

The mechanism is real. The human evidence is not there yet. The "permanent" fat cell claims are not supported by published science. And the DM-for-availability sales approach on an unproven compound is worth treating with significant skepticism.